Article

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

2021-06-09

Abstract excerpt

<h4>ABSTRACT</h4> Beside the isolation and identification of MHC-I restricted peptides from the surface of cancer cells, one of the challenges is eliciting an effective anti-tumor CD8+ T cell mediated response as part of therapeutic cancer vaccine. Therefore, the establishment of a solid pipeline for the downstream selection of clinically relevant peptides and the subsequent creation of therapeutic cancer vaccine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8fa29dc2-af3a-5b6a-b194-4c812f579157
DOI: 10.1101/2021.06.08.447483

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccinesDOI 10.1101/2021.06.08.447483Read

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccinesSemantic proximity Read

Insilico Identification of MHC displayed Tumor Associated Peptides in Ovarian Cancer for Multi-Epitope Vaccine ConstructSemantic proximity Read

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinomaSemantic proximity Read

An in situ immunogenicity-amplifying payload delivery system for immunotherapy of Kirsten rat sarcoma viral oncogene homolog-mutant cancer.Semantic proximity Read

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineSemantic proximity Read

Identification of tumor-specific MHC ligands through improved biochemical isolation and incorporation of machine learningSemantic proximity Read

A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer.Semantic proximity Read

Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma.Semantic proximity Read

Novel Immune Drug Combination Induces Tumour Microenvironment Remodelling and Reduces the Dosage of Anti-PD-1 AntibodySemantic proximity Read

Deciphering the tumor-specific immunopeptidome in vivo with genetically engineered mouse modelsSemantic proximity Read

Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responsesSemantic proximity Read

Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV.Semantic proximity Read